Skip to content
Awesome – Lifestyle
Author:
Faron Pharmaceuticals
Faron Pharmaceuticals Ltd: Results of the Extraordinary General Meeting
March 5, 2026
Faron and City of Hope in Process of Developing a Phase II Investigator-Initiated Trial of Bexmarilimab in Relapsed/Refractory MDS
March 5, 2026
←
Previous Page
1
2
3
4